As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...

Successful trials carried out by the University of Birmingham has found a breakthrough in diabetes ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes ...

Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Managing type 1 diabetes during cold weather requires extra attention to how you store insulin, use your devices, and manage ...

Healthcare workers are observing that chronic conditions such as heart disease, stroke, and diabetes are increasingly being diagnosed in younger adults, includi ...

New research has shown that the introduction childhood screening for type 1 diabetes is ‘effective’ and would help reduce ...

Type 1 diabetes is a chronic autoimmune condition affecting over 9 million people worldwide, caused by the body's immune system attacking the insulin-producing cells in the pancreas, resulting in high ...

For a long time, treatments for autoimmune diseases could only quash the symptoms - now new drugs may tackle the underlying ...